Having trouble accessing articles? Reset your cache.

Angiomax bivalirudin: Additional Phase III data

Three-year follow-up data from the single-blind, international Phase III HORIZONS AMI trial in 3,602 patients showed that Angiomax given during angioplasty compared with heparin plus a

Read the full 261 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE